Without cystic fibrosis transmembrane conductance regulator–mediated (CFTR-mediated) HCO3– secretion, airway epithelia of newborns with cystic fibrosis (CF) produce an abnormally acidic airway surface liquid (ASL), and the decreased pH impairs respiratory host defenses. However, within a few months of birth, ASL pH increases to match that in non-CF airways. Although the physiological basis for the increase is unknown, this time course matches the development of inflammation in CF airways. To learn whether inflammation alters CF ASL pH, we treated CF epithelia with TNF-α and IL-17 (TNF-α+IL-17), 2 inflammatory cytokines that are elevated in CF airways. TNF-α+IL-17 markedly increased ASL pH by upregulating pendrin, an apical Cl–/HCO3– exchanger. Moreover, when CF epithelia were exposed to TNF-α+IL-17, clinically approved CFTR modulators further alkalinized ASL pH. As predicted by these results, in vivo data revealed a positive correlation between airway inflammation and CFTR modulator–induced improvement in lung function. These findings suggest that inflammation is a key regulator of HCO3– secretion in CF airways. Thus, they explain earlier observations that ASL pH increases after birth and indicate that, for similar levels of inflammation, the pH of CF ASL is abnormally acidic. These results also suggest that a non-cell-autonomous mechanism, airway inflammation, is an important determinant of the response to CFTR modulators.
Tayyab Rehman, Philip H. Karp, Ping Tan, Brian J. Goodell, Alejandro A. Pezzulo, Andrew L. Thurman, Ian M. Thornell, Samantha L. Durfey, Michael E. Duffey, David A. Stoltz, Edward F. McKone, Pradeep K. Singh, Michael J. Welsh
Title and authors | Publication | Year |
---|---|---|
Cystic fibrosis airway inflammation enables elexacaftor/tezacaftor/ivacaftor-mediated rescue of N1303K CFTR mutation
Gentzsch M, Baker B, Cholon DM, Kam CW, McKinzie CJ, Despotes KA, Boyles SE, Quinney NL, Esther CR Jr, Ribeiro CM |
ERJ Open Research | 2024 |
Multiple Regulatory Signals and Components in the Modulation of Bicarbonate Transporters.
Kim HJ, Hong JH |
Pharmaceutics | 2024 |
Representation and quantification of module activity from omics data with rROMA.
Najm M, Cornet M, Albergante L, Zinovyev A, Sermet-Gaudelus I, Stoven V, Calzone L, Martignetti L |
npj Systems Biology and Applications | 2024 |
TWO RARE VARIANTS THAT AFFECT THE SAME AMINO ACID IN CFTR HAVE DISTINCT RESPONSES TO IVACAFTOR
Li H, Rodrat M, Al-Salmani MK, Veselu DF, Han ST, Raraigh KS, Cutting GR, Sheppard DN |
The Journal of Physiology | 2024 |
Epithelial responses to CFTR modulators are improved by inflammatory cytokines and impaired by anti-inflammatory drugs
Tayyab Rehman, Alejandro Pezzulo, Andrew Thurman, Rachel Zemans, Michael Welsh |
JCI Insight | 2024 |
Editorial: Advancing therapeutic strategies: exploring ABC transporters and chemicals affecting their expression and function for disease treatment
Veit G, Matsuo M, Okiyoneda T |
Frontiers in pharmacology | 2024 |
Dynamic measurement of airway surface liquid volume with an ex vivo trachea-chip
Scott M, Lei L, Bierstedt KC, McCray PB Jr, Xie Y |
Lab on a Chip | 2024 |
Comparison of a novel potentiator of CFTR channel activity to ivacaftor in ameliorating mucostasis caused by cigarette smoke in primary human bronchial airway epithelial cells
Tanjala AC, Jiang JX, Eckford PD, Ramjeesingh M, Li C, Huan LJ, Langeveld G, Townsend C, Paone DV, Busch-Petersen J, Pekhletski R, Tang L, Raju V, Rowe SM, Bear CE |
Respiratory Research | 2024 |
Disease-specific transcriptional programs govern airway goblet cell metaplasia
Li K, Song Z, Yue Q, Wang Q, Li Y, Zhu Y, Chen H |
Heliyon | 2024 |
Cystic fibrosis.
Mall MA, Burgel PR, Castellani C, Davies JC, Salathe M, Taylor-Cousar JL |
Nature Reviews Disease Primers | 2024 |
Predictors of Sinonasal Improvement After Highly Effective Modulator Therapy in Adults with Cystic Fibrosis.
Beswick DM, Liu CM, Overdevest JB, Zemke A, Khatiwada A, Gudis DA, Miller JE, Kimple A, Tervo JP, DiMango E, Goralski JL, Keating C, Senior B, Stapleton AL, Eshaghian PH, Mace JC, Markarian K, Alt JA, Bodner TE, Chowdhury NI, Getz AE, Hwang PH, Khanwalker A, Lee JT, Li DA, Norris M, Nayak JV, Owens C, Patel ZM, Poch K, Schlosser RJ, Smith KA, Smith TL, Soler ZM, Suh JD, Turner GA, Wang MB, Saavedra MT, Taylor Cousar JL |
The Laryngoscope | 2024 |
Allergic Bronchopulmonary Aspergillosis (ABPA) in the Era of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
Chatterjee P, Moss CT, Omar S, Dhillon E, Hernandez Borges CD, Tang AC, Stevens DA, Hsu JL |
Journal of Fungi | 2024 |
From CFTR to a CF signalling network: a systems biology approach to study Cystic Fibrosis
Najm M, Martignetti L, Cornet M, Kelly-Aubert M, Sermet I, Calzone L, Stoven V |
BMC Genomics | 2024 |
Impact of Gene Modifiers on Cystic Fibrosis Phenotypic Profiles: A Systematic Review
Ward A, Mauleon R, Ooi CY, Rosic N |
Human Mutation | 2024 |
Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators
Ribeiro CM, Higgs MG, Muhlebach MS, Wolfgang MC, Borgatti M, Lampronti I, Cabrini G |
International journal of molecular sciences | 2023 |
Inflammation as a Regulator of the Airway Surface Liquid pH in Cystic Fibrosis
Rehman T, Welsh MJ |
Cells | 2023 |
Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies
Carbone A, Vitullo P, Di Gioia S, Conese M |
Genes & development | 2023 |
Pathogenicity and virulence of Aspergillus fumigatus
Earle K, Valero C, Conn DP, Vere G, Cook PC, Bromley MJ, Bowyer P, Gago S |
Virulence | 2023 |
Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epithelium
Zajac M, Lepissier A, Dréano E, Chevalier B, Hatton A, Kelly-Aubert M, Guidone D, Planelles G, Edelman A, Girodon E, Hinzpeter A, Crambert G, Pranke I, Galietta LJ, Sermet-Gaudelus I |
Frontiers in pharmacology | 2023 |
Losartan ameliorates TGF-β1-induced CFTR dysfunction and improves correction by cystic fibrosis modulator therapies
Michael D. Kim, Charles Bengtson, Makoto Yoshida, Asef J. Niloy, John Dennis, Nathalie Baumlin, Matthias Salathe |
Journal of Clinical Investigation | 2022 |
Ivacaftor Alters Macrophage and Lymphocyte Infiltration in the Lungs Following Lipopolysaccharide Exposure
Harwood KH, McQuade RM, Jarnicki A, Schneider-Futschik EK |
2022 | |
IL-17 Cytokines and Chronic Lung Diseases
Ritzmann F, Lunding LP, Bals R, Wegmann M, Beisswenger C |
Cells | 2022 |
The surface of airway epithelia exposed to IL-17/TNF-α switches between a hyperviscous and a fluid state under beta-adrenergic control
Daniela Guidone, Martina Buccirossi, Paolo Scudieri, Michele Genovese, Sergio Sarnataro, Rossella Cegli, Federico Cresta, Vito Terlizzi, Gabrielle Planelles, Gilles Crambert, Isabelle Sermet, Luis Galietta |
JCI Insight | 2022 |
The CFTR Amplifier Nesolicaftor Rescues TGF-β1 Inhibition of Modulator-Corrected F508del CFTR Function
Bengtson C, Silswal N, Baumlin N, Yoshida M, Dennis J, Yerrathota S, Kim M, Salathe M |
International journal of molecular sciences | 2022 |
WNK Inhibition Increases Surface Liquid pH and Host Defense in Cystic Fibrosis Airway Epithelia.
Rehman T, Karp PH, Thurman AL, Mather SE, Jain A, Cooney AL, Sinn PL, Pezzulo AA, Duffey ME, Welsh MJ |
American journal of respiratory cell and molecular biology | 2022 |
A Nod and a WNK (Kinase): Understanding Airway Surface Liquid pH.
Cook DP, Peebles RS Jr |
American journal of respiratory cell and molecular biology | 2022 |
Impact of CFTR Modulators on the Impaired Function of Phagocytes in Cystic Fibrosis Lung Disease.
Meoli A, Eickmeier O, Pisi G, Fainardi V, Zielen S, Esposito S |
International journal of molecular sciences | 2022 |
The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation
Caverly LJ, Riquelme SA, Hisert KB |
Clinics in Chest Medicine | 2022 |
Bicarbonate Transport in Cystic Fibrosis and Pancreatitis
D Angyal, M Bijvelds, M Bruno, M Peppelenbosch, H de Jonge |
Cells | 2021 |
Impact of Airway Inflammation on the Efficacy of CFTR Modulators
CM Ribeiro, M Gentzsch |
Cells | 2021 |